IL145117A0 - Encapsulation of bioactive complexes in liposomes - Google Patents

Encapsulation of bioactive complexes in liposomes

Info

Publication number
IL145117A0
IL145117A0 IL14511700A IL14511700A IL145117A0 IL 145117 A0 IL145117 A0 IL 145117A0 IL 14511700 A IL14511700 A IL 14511700A IL 14511700 A IL14511700 A IL 14511700A IL 145117 A0 IL145117 A0 IL 145117A0
Authority
IL
Israel
Prior art keywords
liposomes
encapsulation
nucleic acids
bioactive complexes
bioactive agents
Prior art date
Application number
IL14511700A
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of IL145117A0 publication Critical patent/IL145117A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
IL14511700A 1999-03-02 2000-03-01 Encapsulation of bioactive complexes in liposomes IL145117A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12236599P 1999-03-02 1999-03-02
PCT/US2000/005395 WO2000051565A1 (en) 1999-03-02 2000-03-01 Encapsulation of bioactive complexes in liposomes

Publications (1)

Publication Number Publication Date
IL145117A0 true IL145117A0 (en) 2002-06-30

Family

ID=22402271

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14511700A IL145117A0 (en) 1999-03-02 2000-03-01 Encapsulation of bioactive complexes in liposomes

Country Status (20)

Country Link
US (2) US7491409B1 (de)
EP (1) EP1156783B1 (de)
JP (1) JP2002538096A (de)
KR (1) KR20010112301A (de)
CN (1) CN1349402A (de)
AT (1) ATE376413T1 (de)
AU (1) AU3715900A (de)
BR (1) BR0008711A (de)
CA (1) CA2362485A1 (de)
CZ (1) CZ20013103A3 (de)
DE (1) DE60036861T2 (de)
EA (1) EA200100856A1 (de)
ES (1) ES2295018T3 (de)
HU (1) HUP0200114A2 (de)
IL (1) IL145117A0 (de)
NO (1) NO20014231L (de)
NZ (1) NZ513829A (de)
PL (1) PL351487A1 (de)
WO (1) WO2000051565A1 (de)
ZA (1) ZA200107205B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0008711A (pt) * 1999-03-02 2002-10-01 Liposome Co Inc Encapsulação de complexos bioativos em lipossomas
ES2336766T3 (es) 2000-10-04 2010-04-16 Kyowa Hakko Kirin Co., Ltd. Procedimiento de recubrimiento de particulas finas con pelicula lipidica.
WO2002080981A2 (en) * 2001-04-04 2002-10-17 Nordic Vaccine Technology A/S Polynucleotide binding complexes comprising sterols and saponins
US7713942B2 (en) 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
WO2003059279A2 (en) * 2002-01-09 2003-07-24 Elan Pharmaceuticals, Inc. Efficient liposomal encapsulation under mild conditions
EP1478341A4 (de) * 2002-01-09 2009-05-20 Transave Inc Wirksame nukleinsäureverkapselung in mittelgrossen liposomen
EP1490013B1 (de) 2002-03-07 2010-02-17 University Of Delaware Verfahren zur verstärkung der oligonucleotid-vermittelten nucleinsäuresequenzänderung unter verwendung von zusammensetzungen mit einem hydroxyharnstoff
JP2005529959A (ja) * 2002-06-14 2005-10-06 マイラス コーポレイション 細胞へのポリヌクレオチドの伝達をするための新規な方法
ES2640060T3 (es) * 2005-01-28 2017-10-31 Kyowa Hakko Kirin Co., Ltd. Proceso para producir una partícula fina revestida
EP1867726A4 (de) * 2005-03-24 2008-09-24 Univ Hokkaido Nat Univ Corp Zur wirksamen zuführung einer gegebenen substanz in den zellkern fähiges liposom
WO2007037444A1 (ja) * 2005-09-30 2007-04-05 National University Corporation Hokkaido University 目的物質を核内又は細胞内に送達するためのベクター
ATE523787T1 (de) * 2007-05-31 2011-09-15 Sanofi Sa Testverfahren zur erkennung von wirkstoffen zur modifizierung der aktivität von nape-pld oder abh4
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
WO2009127060A1 (en) 2008-04-15 2009-10-22 Protiva Biotherapeutics, Inc. Novel lipid formulations for nucleic acid delivery
EP4241767A3 (de) 2008-11-10 2023-11-01 Arbutus Biopharma Corporation Neuartige lipide und zusammensetzungen zur verabreichung von therapeutika
WO2011000107A1 (en) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
US20110177147A1 (en) 2010-01-21 2011-07-21 General Electric Company Stable biocidal delivery systems
KR101102834B1 (ko) * 2010-02-24 2012-01-05 충남대학교산학협력단 신규한 리포좀 제조 방법 및 장치
KR101198715B1 (ko) * 2010-05-14 2012-11-13 한국생명공학연구원 핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
WO2012000104A1 (en) 2010-06-30 2012-01-05 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
FR2964569B1 (fr) * 2010-09-10 2012-10-19 Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad Nouveaux liposomes de vaccination genique
CN103501821A (zh) * 2011-03-08 2014-01-08 艾克塞斯制药公司 用于递送活性剂穿过生物膜的靶向纳米载体系统
WO2012148397A1 (en) 2011-04-28 2012-11-01 Aquero Company, Llc Lysine-based polymer coagulants for use in clarification of process waters
CN105209024B (zh) 2013-05-17 2018-04-27 3M创新有限公司 生物活性剂从聚合物复合颗粒的释放
CN105228820B (zh) 2013-05-17 2017-08-29 3M创新有限公司 反应混合物、多孔粒子以及制备方法
CA3106893A1 (en) * 2018-07-21 2020-01-30 University Of Tennessee Research Foundation Neutral liposomes containing biologically active agents
EP3946365A4 (de) * 2019-03-29 2023-04-19 Glycomine, Inc. Liposomale formulierungen und verfahren zu deren verwendung und deren herstellung
EP3739321B1 (de) * 2019-05-17 2023-03-08 Xtal Concepts GmbH Qualifizierungsverfahren für kryoelektronenmikroskopie-proben sowie dazugehöriger probenhalter
WO2022045009A1 (ja) * 2020-08-24 2022-03-03 国立大学法人山口大学 流体を追跡するための組成物及び流体の追跡方法
CA3210451A1 (en) 2021-03-22 2022-09-29 Illumina Cambridge Limited Methods for improving nucleic acid cluster clonality
CN113785975B (zh) * 2021-09-09 2023-08-29 天津医科大学 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用
DE102022134188B3 (de) 2022-12-20 2024-03-28 Universität Augsburg - Körperschaft des öffentlichen Rechts Verfahren zur in-situ Erfassung von Änderungen eines Lipidsystems bei dessen Lagerung bei einer Lagertemperatur unterhalb von -60 °C

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723147A (en) 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5286634A (en) * 1989-09-28 1994-02-15 Stadler Joan K Synergistic method for host cell transformation
DK0695169T3 (da) * 1993-04-22 2003-03-17 Skyepharma Inc Multivesikulære liposomer med indkapslet cyclodextrin og farmakologisk aktive forbindelser samt fremgangsmåder til anvendelse af disse
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
PT956001E (pt) * 1996-11-12 2012-12-06 Univ California Preparação de formulações estáveis de complexos do tipo lípido-ácido nucleico para uma entrega eficiente in vivo
BR0008711A (pt) * 1999-03-02 2002-10-01 Liposome Co Inc Encapsulação de complexos bioativos em lipossomas

Also Published As

Publication number Publication date
NZ513829A (en) 2001-09-28
KR20010112301A (ko) 2001-12-20
DE60036861D1 (de) 2007-12-06
NO20014231D0 (no) 2001-08-31
PL351487A1 (en) 2003-04-22
WO2000051565A1 (en) 2000-09-08
HUP0200114A2 (hu) 2002-05-29
AU3715900A (en) 2000-09-21
EP1156783A1 (de) 2001-11-28
ES2295018T3 (es) 2008-04-16
CZ20013103A3 (cs) 2002-01-16
US7491409B1 (en) 2009-02-17
WO2000051565A9 (en) 2002-02-14
NO20014231L (no) 2001-10-03
EP1156783B1 (de) 2007-10-24
ZA200107205B (en) 2002-12-02
CN1349402A (zh) 2002-05-15
JP2002538096A (ja) 2002-11-12
US20090068256A1 (en) 2009-03-12
BR0008711A (pt) 2002-10-01
DE60036861T2 (de) 2008-07-24
EA200100856A1 (ru) 2002-02-28
EP1156783A4 (de) 2003-05-21
CA2362485A1 (en) 2000-09-08
ATE376413T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
IL145117A0 (en) Encapsulation of bioactive complexes in liposomes
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
WO2002074238A3 (en) Water soluble and palatable complexes
DE60138566D1 (en) Selbstformende thermodynamisch stabile liposome
AU2001232377A1 (en) The method of advertisement using online games
EP1015008A4 (de) Verbindungen und zusammensetzungen zur administration aktiver stoffe
EP1337504A4 (de) Neue polyaminanalogon-aminosäure-konjugate zur verwendung als krebsmittel
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
WO1999013816A3 (en) Liposomal camptothecin formulations
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
AU6838501A (en) Enzyme-catalyzed polyamides and compositions and processes of preparing and using the same
EP0707844A3 (de) Abgabe von Zusammensetzungen zur Verstärkung der Bräunung und Besserung von UV Schäden durch Liposomen
WO2002015959A3 (en) Compounds and compositions for delivering active agents
PL345985A1 (en) Arrangement of slip-rings used in electric motors and generators, body incorporating such arrangement of slip-rings and method of remaking such bodies
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
WO2000053231A3 (en) Fatty acid-anticancer conjugates and uses thereof
CA2402708A1 (en) Torasemide-containing pharmaceutical preparations
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
MXPA03011190A (es) Peptidos biologicamente activos.
NZ528544A (en) Formulations comprising entrapped active ingredients and uses thereof
AU6099898A (en) Method for producing surfactant pearly luster concentrates
ITBO990663A0 (it) Macchina per la realizzazione di sacchetti - filtro per prodotti da in fusione .
DE50208813D1 (en) (ester)-lysolecithine in liposomen
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.